{"id":"bay14-2222-kogenate-fs-fviii","safety":{"commonSideEffects":[{"rate":"10%","effect":"Headache"},{"rate":"8%","effect":"Nausea"},{"rate":"6%","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL4297956","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"BAY14-2222_Kogenate-FS FVIII is a recombinant human coagulation factor VIII used to treat hemophilia A.","oneSentence":"Factor VIII replacement therapy","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:22:13.335Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hemophilia A"}]},"trialDetails":[{"nctId":"NCT02263066","phase":"","title":"Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular Prophylaxis","status":"COMPLETED","sponsor":"Bayer","startDate":"2014-10","conditions":"Hemophilia A","enrollment":181}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"BAY14-2222_Kogenate-FS FVIII","genericName":"BAY14-2222_Kogenate-FS FVIII","companyName":"Bayer","companyId":"bayer","modality":"Biologic","firstApprovalDate":"","aiSummary":"Factor VIII replacement therapy Used for Hemophilia A.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}